Related Experiment Video
Updated: Jan 31, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Relative Dose Intensity and Outcomes in Elderly Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant
Tsuyoshi Takeda1, Masato Ozaka1, Takashi Sasaki1
1Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Neoadjuvant chemotherapy (NAC) with gemcitabine and S-1 (GS) is feasible for elderly patients with resectable pancreatic cancer (PC). However, reduced dose intensity and increased AEs were observed in elderly patients and those with impaired renal function.
Area of Science:
- Oncology
- Gastroenterology
- Pharmacology
Background:
- Gemcitabine and S-1 (GS) neoadjuvant chemotherapy (NAC) is standard for resectable pancreatic cancer (PC) in Japan.
- Efficacy and safety of NAC GS in elderly patients and those with renal impairment are not well-established.
Purpose of the Study:
- To evaluate the efficacy and safety of NAC GS in elderly patients with resectable PC.
- To assess the impact of age and renal function on NAC GS outcomes.
Main Methods:
- Retrospective analysis of 185 patients with resectable PC who received NAC GS.
- Patients were categorized as elderly (≥75 years) or non-elderly (<75 years).
- Primary endpoint: relative dose intensity (RDI) of NAC; Secondary endpoints: adverse events (AEs), perioperative outcomes, adjuvant chemotherapy (AC) RDI, recurrence-free survival (RFS), and overall survival (OS).
Main Results:
- Elderly patients had significantly lower creatinine clearance (CCr) and mean RDI of GS.
- Lower RDI of GS was particularly noted in elderly patients with CCr <50 mL/min.
- Severe hematologic AEs were more frequent in elderly patients; however, perioperative outcomes, RFS, and OS did not significantly differ between age groups.
Conclusions:
- NAC GS is feasible in elderly patients with resectable PC.
- Caution is advised for elderly patients with impaired renal function due to potential dose reductions and increased AEs.
- Further research may be needed to optimize NAC GS regimens for specific patient subgroups.
Related Concept Videos
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Receiver Operating Characteristic Plot
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Sound Intensity

